CSX Corporation vs TransMedics Group Inc — how do they compare? CSX Corporation trades at $50.1 (market cap $92.55B), while TransMedics Group Inc trades at $89.4 (market cap $3.10B). The key difference: CSX Corporation is far larger — about 29.9× TransMedics Group Inc's market cap, and CSX Corporation pays a 1.12% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals.
| CSX | TMDX | |
|---|---|---|
Market Cap | $92.55B | $3.10B |
Sector | Industrials | Technology |
52-Week High | $53.21 | $150.42 |
52-Week Low | $32.05 | $61.99 |
Enterprise Value | $110.52B | $3.49B |
Dividend Yield | 1.12% | — |
Signals from Pluang's Aura AI — not financial advice
CSX trades at $50.12, down 0.3% on the day, with a neutral technical signal. Recent Q2 2026 earnings beat estimates with EPS of $0.54 versus $0.518 expected, driven by 10% revenue growth and margin expansion. The stock's valuation ratios, including a P/E of 29.05 and P/S of 6.41, reflect a premium pricing relative to historical levels. Analyst consensus is bullish with a $52.57 price target, supported by 58.69% buy ratings.
The outlook for CSX is positive, with projected 2026 revenue growth and improved cash flow. Key opportunities include strong intermodal demand and operational efficiency gains. Risks involve competitive pressures, fuel cost volatility, and potential economic slowdowns affecting freight volumes. The stock's current level offers a moderate upside to the consensus target, balanced by elevated valuation multiples.
No Aura AI signal available yet.
Trailing returns across standard periods
Operating in the Eastern United States, Class I railroad CSX generated revenue near $12.5 billion in 2021. On its more than 21,000 miles of track, CSX hauls shipments of coal (13% of consolidated revenue), chemicals (22%), intermodal containers (16%), automotive cargo (9%), and a diverse mix of other bulk and industrial merchandise.
Read more on CSX →TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →